About this episode
In The Tox Talks we feature expert injectors with significant experience using botulinum toxins, exploring their experience with particular brands, how their techniques have evolved and the subtle nuances of getting the best from toxins.
In Chapter 11 we discuss Relfydess, a new botulinum toxin type A from Galderma, with Melbourne nurse injector Mike Clague (previously on Episode 276).
Mike shares his involvement in the pre-launch trials and his clinical experience with the product. We cover its efficacy and onset compared with other toxins, performance across facial areas, dosing, manufacturing and purity, antibodies, longevity and practical tips for injectors, plus training, mentorship and advertising compliance.
What you'll learn
- What Relfydess is and how it was trialled
- Onset, efficacy and longevity compared with other toxins
- Dosing and injection techniques by area
- Manufacturing, purity and antibody considerations
- The commercial impact of treatment frequency
- Advertising compliance for toxin treatments
Topics
- The Tox Talks
- Botulinum toxin
- Relfydess
- Galderma
- Toxin longevity
- Injection technique
- Nurse injectors
Full transcript
The full transcript for this episode is coming soon.